Enzymatic Activity of the Staphylococcus aureus SplB Serine Protease is Induced by Substrates Containing the Sequence Trp-Glu-Leu-Gln

Journal of Molecular Biology

Volumn 379, Issue 2, 2008, Pages 343-356

  Dubin, Grzegorz ^a   Stec Niemczyk, Justyna ^a   Kisielewska, Magdalena ^a   Pustelny, Katarzyna ^a   Popowicz, Grzegorz M ^b   Bista, Michal ^a,b   Kantyka, Tomasz ^a   Boulware, Kevin T ^c   Stennicke, Henning R ^d   Czarna, Anna ^a,b   Phopaisarn, Mullika ^a   Daugherty, Patrick S ^c   Thøgersen, Ida B ^e   Enghild, Jan J ^e   Thornberry, Nancy ^f   Dubin, Adam ^a,g   Potempa, Jan ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c University of California   (United States)

^d NOVO NORDISK A S   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f MERCK RESEARCH LABORATORIES   (United States)

^g BioCentrum Ltd   (Poland)

Author keywords

protease; Staphylococcus aureus; structure; substrate specificity

Indexed keywords

BACTERIAL ENZYME; GLUTAMIC ACID; GLUTAMINE; LEUCINE; SERINE PROTEINASE; SPLB SERINE PROTEASE; TRYPTOPHAN;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; CONFORMATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 43049098167     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.03.059     Document Type: Article

References (66)

1. C.A. Morin J.L. Hadler Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998 J. Infect. Dis. 184 2001 1029 1034
2. F.D. Lowy Staphylococcus aureus infections N. Engl. J. Med. 339 1998 520 532
3. T.G. Emori R.P. Gaynes An overview of nosocomial infections, including the role of the microbiology laboratory Clin. Microbiol. Rev. 6 1993 428 442
4. D.J. Diekema M.A. Pfaller F.J. Schmitz J. Smayevsky J. Bell R.N. Jones M. Beach Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999 Clin. Infect. Dis. 32 Suppl 2 2001 S114 S132
5. H.S. Sader R.N. Jones A.C. Gales J.B. Silva A.C. Pignatari SENTRY Antimicrobial Surveillance Program report: Latin American and Brazilian results for 1997 through 2001 Braz. J. Infect. Dis. 8 2004 25 79
6. National Nosocomial Infections Surveillance System National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986–April 1998, issued June 1998 Am. J. Infect. Control 26 1998 522 533
7. B.S. Cooper S.P. Stone C.C. Kibbler B.D. Cookson J.A. Roberts G.F. Medley Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus : a review of the literature with epidemiological and economic modelling Health Technol. Assess. 7 2003 1 194
8. R.H. Drew Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections Pharmacotherapy 27 2007 227 249
9. J.A. Lindsay M.T. Holden Staphylococcus aureus : superbug, super genome? Trends Microbiol. 12 2004 378 385
10. S.B. Reed C.A. Wesson L.E. Liou W.R. Trumble P.M. Schlievert G.A. Bohach K.W. Bayles Molecular characterization of a novel Staphylococcus aureus serine protease operon Infect. Immun. 69 2001 1521 1527
11. M. Kuroda T. Ohta I. Uchiyama T. Baba H. Yuzawa I. Kobayashi Whole genome sequencing of methicillin-resistant Staphylococcus aureus Lancet 357 2001 1225 1240
12. G.M. Popowicz G. Dubin J. Stec-Niemczyk A. Czarny A. Dubin J. Potempa T.A. Holak Functional and structural characterization of Spl proteases from Staphylococcus aureus J. Mol. Biol. 358 2006 270 279
13. K. Rieneck J. Renneberg M. Diamant E. Gutschik K. Bendtzen Molecular cloning and expression of a novel Staphylococcus aureus antigen Biochim. Biophys. Acta 1350 1997 128 132
14. C.J. Bailey M.B. Redpath The esterolytic activity of epidermolytic toxins Biochem. J. 284 Pt 2 1992 177 180
15. M.B. Redpath T.J. Foster C.J. Bailey The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus FEMS Microbiol. Lett. 65 1991 151 155
16. M. Amagai T. Yamaguchi Y. Hanakawa K. Nishifuji M. Sugai J.R. Stanley Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1 J. Invest. Dermatol. 118 2002 845 850
17. S.C. Wu S.L. Wong Development of improved pUB110-based vectors for expression and secretion studies in Bacillus subtilis J. Biotechnol. 72 1999 185 195
18. S.J. Snipas E. Wildfang T. Nazif L. Christensen K.M. Boatright M. Bogyo Characteristics of the caspase-like catalytic domain of human paracaspase Biol. Chem. 385 2004 1093 1098
19. T.A. Rano T. Timkey E.P. Peterson J. Rotonda D.W. Nicholson J.W. Becker A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE) Chem. Biol. 4 1997 149 155
20. K.T. Boulware P.S. Daugherty Protease specificity determination by using cellular libraries of peptide substrates (CLiPS) Proc. Natl Acad. Sci. USA 103 2006 7583 7588
21. J. Cavarelli G. Prevost W. Bourguet L. Moulinier B. Chevrier B. Delagoutte The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 Å resolution Structure 5 1997 813 824
22. G.M. Vath C.A. Earhart D.D. Monie J.J. Iandolo P.M. Schlievert D.H. Ohlendorf The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity Biochemistry 38 1999 10239 10246
23. A.G. Olivero C. Eigenbrot R. Goldsmith K. Robarge D.R. Artis J. Flygare A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo J. Biol. Chem. 280 2005 9160 9169
24. 2+ sites in factor VIIa J. Biol. Chem. 281 2006 24873 24888
25. U. Marquardt F. Zettl R. Huber W. Bode C. Sommerhoff The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region J. Mol. Biol. 321 2002 491 502
26. W. Bode R. Huber Natural protein proteinase inhibitors and their interaction with proteinases Eur. J. Biochem. 204 1992 433 451
27. M. Laskowski M.A. Qasim What can the structures of enzyme–inhibitor complexes tell us about the structures of enzyme substrate complexes? Biochim. Biophys. Acta 1477 2000 324 337
28. J.J. Perona C.S. Craik Structural basis of substrate specificity in the serine proteases Protein Sci. 4 1995 337 360
29. J.D. Tyndall T. Nall D.P. Fairlie Proteases universally recognize beta strands in their active sites Chem. Rev. 105 2005 973 999
30. A.R. Khan M.N. James Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes Protein Sci. 7 1998 815 836
31. H. Fehlhammer W. Bode R. Huber Crystal structure of bovine trypsinogen at 1–8 Å resolution: II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin J. Mol. Biol. 111 1977 415 438
32. D. Wang W. Bode R. Huber Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 Å resolution J. Mol. Biol. 185 1985 595 624
33. R. Huber W. Bode Structural basis of the activation and action of trypsin Acc. Chem. Res. 11 1978 114 122
34. H. Nar A. Messerschmidt R. Huber M. van de Kamp G.W. Canters Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5.5 and pH 9.0. A pH-induced conformational transition involves a peptide bond flip J. Mol. Biol. 221 1991 765 772
35. R. Friedrich P. Panizzi P. Fuentes-Prior K. Richter I. Verhamme P.J. Anderson Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation Nature 425 2003 535 539
36. W. Bode R. Huber Induction of the bovine trypsinogen–trypsin transition by peptides sequentially similar to the N-terminus of trypsin FEBS Lett. 68 1976 231 236
37. W. Bode P. Schwager R. Huber The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen–pancreatic trypsin inhibitor complex and of its ternary complex with Ile–Val at 1.9 Å resolution J. Mol. Biol. 118 1978 99 112
38. V.L. Nienaber K. Breddam J.J. Birktoft A glutamic acid specific serine protease utilizes a novel histidine triad in substrate binding Biochemistry 32 1993 11469 11475
39. I.H. Barrette-Ng K.K. Ng B.L. Mark D. Van Aken M.M. Cherney C. Garen Structure of arterivirus nsp4. The smallest chymotrypsin-like proteinase with an alpha/beta C-terminal extension and alternate conformations of the oxyanion hole J. Biol. Chem. 277 2002 39960 39966
40. L. Prasad Y. Leduc K. Hayakawa L.T. Delbaere The structure of a universally employed enzyme: V8 protease from Staphylococcus aureus Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 256 259
41. G.M. Vath C.A. Earhart J.V. Rago M.H. Kim G.A. Bohach P.M. Schlievert D.H. Ohlendorf The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease Biochemistry 36 1997 1559 1566
42. H.R. Stennicke J.J. Birktoft K. Breddam Characterization of the S1 binding site of the glutamic acid-specific protease from Streptomyces griseus Protein Sci. 5 1996 2266 2275
43. I.V. Demidyuk D.V. Romanova E.A. Nosovskaya G.G. Chestukhina I.P. Kuranova S.V. Kostrov Modification of substrate-binding site of glutamyl endopeptidase from Bacillus intermedius Protein Eng. Des. Sel. 17 2004 411 416
44. M. Marquart J. Walter J. Deisenhofer W. Bode R. Huber The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors Acta Crystallogr., Sect. B: Struct. Sci. B39 1983 480 490
45. D. Lu K. Futterer S. Korolev X. Zheng K. Tan G. Waksman J.E. Sadler Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide J. Mol. Biol. 292 1999 361 373
46. C. Montecucco G. Schiavo Mechanism of action of tetanus and botulinum neurotoxins Mol. Microbiol. 13 1994 1 8
47. A.D. Pannifer T.Y. Wong R. Schwarzenbacher M. Renatus C. Petosa J. Bienkowska Crystal structure of the anthrax lethal factor Nature 414 2001 229 233
48. K. Murashima C.L. Chen A. Kosugi Y. Tamaru R.H. Doi S.L. Wong Heterologous production of Clostridium cellulovorans engB, using protease-deficient Bacillus subtilis , and preparation of active recombinant cellulosomes J. Bacteriol. 184 2002 76 81
49. M. Rzychon A. Sabat K. Kosowska J. Potempa A. Dubin Staphostatins: an expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases Mol. Microbiol. 49 2003 1051 1066
50. A.G.W. Leslie Recent changes to the MOSFLM package for processing film and image plate data Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography 26 1992
51. Collaborative Computational Project The CCP4 suite: programs for protein crystallography Acta Crystallogr., Sect. D: Biol. Crystallogr. 50 1994 760 763
52. P.R. Evans Scala Joint CCP4 and ESF-EACBM Newsletter 33 1997 22 24
53. P. Evans Scaling and assessment of data quality Acta Crystallogr., Sect. D: Biol. Crystallogr. 62 2006 72 82
54. A. Vagin A. Teplyakov MOLREP: an automated program for molecular replacement J. Appl. Crystallogr. 30 1997 1022 1025
55. A. Perrakis R. Morris V.S. Lamzin Automated protein model building combined with iterative structure refinement Nat. Struct. Biol. 6 1999 458 463
56. D.E. McRee XtalView/Xfit—a versatile program for manipulating atomic coordinates and electron density J. Struct. Biol. 125 1999 156 165
57. G.N. Murshudov A.A. Vagin E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr., Sect. D: Biol. Crystallogr. 53 1997 240 255
58. A.T. Brunger Free R value: a novel statistical quantity for assessing the accuracy of crystal structures Nature 355 1992 472 475
59. V.S. Lamzin K.S. Wilson Automated refinement of protein models Acta Crystallogr., Sect. D: Biol. Crystallogr. 49 1993 129 147
60. N. Guex M.C. Peitsch SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling Electrophoresis 18 1997 2714 2723
61. W. Apostoluk J. Otlewski Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins Proteins 32 1998 459 474
62. J.A. Barbosa J.W. Saldanha R.C. Garratt Novel features of serine protease active sites and specificity pockets: sequence analysis and modelling studies of glutamate-specific endopeptidases and epidermolytic toxins Protein Eng. 9 1996 591 601
63. E.F. Pettersen T.D. Goddard C.C. Huang G.S. Couch D.M. Greenblatt E.C. Meng T.E. Ferrin UCSF Chimera—a visualization system for exploratory research and analysis J. Comput. Chem. 25 2004 1605 1612
64. W.D. Cornell P. Cieplak C.I. Bayly I.R. Gould K.M. Merz D.M. Ferguson A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules J. Am. Chem. Soc. 117 1995 5179 5197
65. K. Hinsen The Molecular Modeling Toolkit: a new approach to molecular simulations J. Comput. Chem. 21 2000 79 85
66. P. Emsley K. Cowtan Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 2126 2132